Martin Mackay

Affiliations

  • Director at Springworks Therapeutics Inc. (SWTX), 2024-07-30
  • Director at Charles River Laboratories International Inc. (CRL), 2024-05-15
  • Executive Chairman at Rallybio Corp (RLYB), 2024-02-16
  • Director at 5:01 Acquisition Corp. (FVAM), 2020-10-21
  • Evp & Global Head Of R&D at Alexion Pharmaceuticals Inc (ALXN), 2017-03-02
  • Senior Vice President at Pfizer Inc (PFE), 2010-05-18
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
RLYB $10.65 4,496 Officer, Director 282,609 2022-01-11 Filing
RLYB $10.10 5,504 Officer, Director 278,113 2022-01-10 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ALXN $132.50 370 Officer 50,688 2017-03-01 Filing
ALXN $131.70 625 Officer 38,258 2017-02-28 Filing
ALXN $131.20 860 Officer 38,883 2017-02-27 Filing
ALXN $126.84 217 Officer 39,743 2017-02-09 Filing
ALXN $126.88 18 Officer 39,960 2017-02-06 Filing